Update from the 2013 international neurofibromatosis conference

Scott R. Plotkin, Anne C. Albers, Dusica Babovic-Vuksanovic, Jaishri O. Blakeley, Xandra O. Breakefield, Courtney M. Dunn, D. Gareth Evans, Michael J. Fisher, Jan M. Friedman, Marco Giovannini, David H. Gutmann, Michel Kalamarides, Andrea I. Mcclatchey, Ludwine Messiaen, Helen Morrison, David B. Parkinson, Anat O. Stemmer-Rachamimov, Catherine D. Van Raamsdonk, Vincent M. Riccardi, Tena RosserAaron Schindeler, Miriam J. Smith, David A. Stevenson, Nicole J. Ullrich, Thijs van der Vaart, Brian Weiss, Brigitte C. Widemann, Yuan Zhu, Annette C. Bakker, Alison C. Lloyd

Research output: Contribution to journalArticle

16 Scopus citations
Original languageEnglish (US)
Pages (from-to)2969-2978
Number of pages10
JournalAmerican Journal of Medical Genetics, Part A
Volume164
Issue number12
DOIs
StatePublished - Dec 1 2014

Keywords

  • Merlin
  • NF1
  • NF2
  • Neurofibromatosis 1
  • Neurofibromatosis 2
  • Neurofibromin
  • Preclinical models
  • SMARCB1
  • Schwannomatosis
  • Tumor suppressor

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Plotkin, S. R., Albers, A. C., Babovic-Vuksanovic, D., Blakeley, J. O., Breakefield, X. O., Dunn, C. M., Evans, D. G., Fisher, M. J., Friedman, J. M., Giovannini, M., Gutmann, D. H., Kalamarides, M., Mcclatchey, A. I., Messiaen, L., Morrison, H., Parkinson, D. B., Stemmer-Rachamimov, A. O., Van Raamsdonk, C. D., Riccardi, V. M., ... Lloyd, A. C. (2014). Update from the 2013 international neurofibromatosis conference. American Journal of Medical Genetics, Part A, 164(12), 2969-2978. https://doi.org/10.1002/ajmg.a.36754